RT Journal Article
SR Electronic
T1 Effectiveness of Second Wave COVID-19 Response Strategies in Australia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.16.20232843
DO 10.1101/2020.11.16.20232843
A1 Milne, George
A1 Xie, Simon
A1 Poklepovich, Dana
A1 O’Halloran, Dan
A1 Yap, Matthew
A1 Whyatt, David
YR 2020
UL http://medrxiv.org/content/early/2020/11/18/2020.11.16.20232843.abstract
AB Background There is a significant challenge in responding to second waves of COVID-19 cases, with governments being hesitant in introducing hard lockdown measures given the resulting economic impact. In addition, rising case numbers reflect an increase in coronavirus transmission some time previously, so timing of response measures is highly important. Australia experienced a second wave from June 2020 onwards, confined to greater Melbourne, with initial social distancing measures failing to reduce rapidly increasing case numbers. We conducted a detailed analysis of this outbreak, together with an evaluation of the effectiveness of alternative response strategies, to provide guidance to countries experiencing second waves of SARS-Cov-2 transmission.Method An individual-based transmission model was used to 1) describe a second-wave COVID-19 epidemic in Australia; 2) evaluate the impact of lockdown strategies used; and 3) evaluate effectiveness of alternative mitigation strategies. The model was calibrated using daily diagnosed case data prior to lockdown. Specific social distancing interventions were modelled by adjusting person-to-person contacts in mixing locations.Results Modelling earlier activation of lockdown measures are predicted to reduce total case numbers by more than 50%. Epidemic peaks and duration of the second wave were also shown to reduce. Our results suggest that activating lockdown measures when second-wave case numbers first indicated exponential growth, would have been highly effective in reducing COVID-19 cases. The model was shown to realistically predict the epidemic growth rate under the social distancing measures applied, validating the methods applied.Conclusions The timing of social distancing activation is shown to be critical to their effectiveness. Data showing exponential rise in cases, doubling every 7-10 days, can be used to trigger early lockdown measures. Such measures are shown to be necessary to reduce daily and total case numbers, and the consequential health burden, so preventing health care facilities being overwhelmed. Early control of second wave resurgence potentially permits strict lockdown measures to be eased earlier.All authors have seen and approved the manuscript. Research funding from Department of Health, Western Australia and Department of Health, Queensland is acknowledged. The authors confirm that these organisations had no influence on the submitted work, nor are there any competing interests.Competing Interest StatementAll authors have seen and approved the manuscript. Research funding from Department of Health, Western Australia and Department of Health, Queensland is acknowledged. The authors confirm that these organisations had no influence on the submitted work, nor are there any competing interests. Funding StatementResearch funding from Department of Health, Western Australia and Department of Health, Queensland is acknowledged. The authors confirm that these organisations had no influence on the submitted work, nor are there any competing interests.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData contained in paper